The significance of oxidative mechanisms in diseases of the retina;Bedeutung oxidativer mechanismen bei erkrankungen der netzhaut

Klinische Monatsblatter fur Augenheilkunde

Volumn 219, Issue 9, 2002, Pages 631-643

  Augustin, Albert J ^a   Dick, H Burkhard ^b   Offermann, Indre ^a   Schmidt Erfurth, Ursula ^c  

^a Klinikum Karlsruhe   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Univ Augenklinik Lübeck   (Germany)

Author keywords

Age related macular de generation (AMD); Diabetes; Oxidative metabolites; Retina

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GROWTH FACTOR; XANTHINE OXIDASE;

BLUE LIGHT; DIABETIC RETINOPATHY; INFLAMMATION; ISCHEMIA; LIGHT EXPOSURE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; REVIEW; ULTRAVIOLET RADIATION;

EID: 0036753781     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35164     Document Type: Review

References (124)

1. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-450
2. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996; 114: 66-71
3. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zink for age-related macular degeneration and vision loss. AREDS report No. 8. Arch Ophthalmol 2001; 119: 1417-1436
4. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. N Engl J Med 1994; 331: 1480-1487
5. Aiello AP, Pierce AC, Foley ED. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457-10461
6. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxia regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113: 1538-1544
7. Andley UP, Clark BA. Generation of oxidants in the near-UV photooxidation of human lens alpha-crystallin. Invest Ophth Vis Sci 1989; 30: 706-713
8. Armstrong D, Hiramitsu T, Gutteridge J, Nilsson SE. Studies on experimentally induced retinal degeneration. Effect of lipid peroxides on electroretinographic activity in the albino rabbit. Exp Eye Res 1982; 35: 157-171
9. Armstrong D, Santangelo G, Connole E. The distribution of peroxide regulating enzymes in the canine eye. Curr Eye Res 1982; 1: 225 -242
10. Armstrong D, Augustin AJ, Spengler R, Al-Jada A, Nickola T, Grus F. Detection of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998; 212: 410-414
11. Atalla LR, Sevanian A, Rao NA. Immunohistochemical localization of glutathione peroxidase in ocular tissue. Curr Eye Res 1988; 7: 1023 - 1027
12. Augustin AJ, Lutz J. Intestinal, hepatic and renal production of thiobarbituric acid reactive substances and myeloperoxidase activity after temporary aortic occlusion and reperfusion. Life Sci 1992; 49: 961-968
13. Augustin AJ, Spitznas M, Koch F, Grus F, Lutz J. Effects of artificial blood substitutes and vitamin E on ischemia induced retinal oxidative tissue damage. Exp Eye Res 1998; 66: 19-24
14. Ayala MN, Michael R, Söderberg PG. In vivo cataract after repeated exposure to ultraviolet radiation. Exp Eye Res 2000; 70: 451-456
15. Batey DW, Daneshgar KK, Eckhert CD. Flavin levels in the rat retina. Exp Eye Res 1992; 54: 605-609
16. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412
17. Beatty S, Murray IJ, Henson DB, Carden D, Koh H-H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 2001; 42: 439-446
18. Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, Nakanishi K. Formation of Nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew Chemie 2002; 114: 842-844
19. Berendschot TTJM, Goldbohm RA, Klöpping WAA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macufar pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000; 41: 3322-3326
20. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao AY, Katz NB. Identification and quantitation of caroteinoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001; 72: 215-223
21. Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis III: Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res 1984; 3: 67-81
22. Boulton M, Rozanowska M, Rozanowski B. Retinal photodamage. J Photochem Photobiol 2001; 64: 144-161
23. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1996; 271: 21793-21797
24. Braun RD, Linsenmeier RA, Goldstick TK. New perfluorocarbon emulsion improves tisssue oxygenation in cat retina. J Appl Physiol 1992; 72: 1960-1968
25. Brownlee M, Leramie A. The biochemistry of the complications of diabetes mellitus. Ann Rev Biochem 1981; 50: 385-432
26. Brownlee M, Ceramie A, Vlassara H. Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
27. Ceriello A, Gugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. Diabetes Care 1991; 14: 68-72
28. Crockett RS, Lawwill T. Oxygen dependence of damage by 435 nm light in cultured retinal epithelium. Curr Eye Res 1984; 3: 209- 222
29. De La Paz MA, Anderson RE. Lipid peroxidation in rod outer segments. Invest Ophth Vis Sci 1992a; 33: 2091-2096
30. De La Paz MA, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophth Vis Sci 1992b; 33: 3497-3499
31. Dillon J. Photolytic changes in lens proteins. Curr Eye Res 1984; 3: 145-157
32. Dorey CK, Khouri GG, Syniuta LA, Curran SA, Weiter JJ. Superoxide production by porcine retinal pigment epithelium in vitro. Invest Ophth Vis Sci 1989; 30: 1047-1053
33. Evans JR. Risk factors for age-related macular degeneration. Progress Ret and Eye Res 2001; 20: 227-253
34. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993; 111: 104-109
35. FASEB Meeting Report. Anti-oxidants may reduce retinopathy risk for diabetes. Cataract & Refractive Surgery. Euro Times, May-June, 1998: 29
36. Flower RW, Snyder WJ. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization. Retina 1999; 19: 365-369
37. Gaillard ER, Atherton SJ, Eldred G, Dillon J. Photophysical studies on human retinal lipofuscin. Photochem Photobiol 1995; 61: 448-453
38. Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol 1991; 75: 532-534
39. Glass P. Light and the developing retina. Doc Ophthalmol 1990; 74: 195-203
40. Gottsch JD, Bynoe LA, Harlan JB, Rencs EV, Green WR. Light-induced deposits in Bruch's Membrane of protoporphyric mice. Arch Ophth 1993; 111: 126-129
41. Granger DN, Rutili G, McCord JMC. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981; 81: 22-29
42. Granger DN, Parks DA. The role of oxygen-free radicals in the pathogenesis of intestinal ischemia. Physiologist 1983; 26: 159-164
43. Ham WT, Mueller HA, Ruffolo JJ, Millen JE, Cleary SF, Guerry EK, Guerry D. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984; 3: 165-174
44. Hammond BR, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am 1997a; 14: 1187-1196
45. Hammond BR, Wooten BR, Snodderly DM. Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci 1997b; 74: 499-504
46. Handa JT, Reiser KM, Matsunaga H, Hjelmeland LM. The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells. Exp Eye Res 1998; 66: 411-419
47. Hayes KC. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophth Vis Sci 1974; 13: 499-510
48. Hearse DJ, Manning AS, Downey JM, Yellon DM. Xanthin oxidase: A critical mediator of myocardial injury during ischemia and reperfusion. Acta Physiol Scand 1986; 548: 65-78
49. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1988; 37: 832-837
50. Hirata C, Nakano K, Nakamura N. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem Biophys Res Commun 1997; 236: 712-715
51. IARC. IARC Handbooks of Cancer Prevention: Vol. 2 Carotenoids. Oxford: Oxford University Press, 1998
52. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human and red blood cells. J Biol Chem 1989; 264: 21340-21345
53. Jennings PE, Barnett AH. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabet Med 1988; 5: 111-117
54. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 2001; 391: 160-164
55. Karpen CW, Pritchard KA, Arnold JH. Restoration of prostacyclin/ thromboxane A balance in the diabetic rat. Influence of Dietary Vitamin E. Diabetes 1982; 31: 947-951
56. Karpen CW, Cataland S, D'Dorisio TM, Panganamala RV. Production of 12-HETE and vitamin E status in patients of type I human diabetic subjects. Diabetes 1985; 34: 526-531
57. Katz B. Migrainous central retinal artery occlusion. J Clin Neuro-Ophthalmol 1986; 6: 69-78
58. Kaul K, Lamm KW, Fong T, Lock C, Perry M, Treble D. Ascorbate peroxidase in bovine retinal pigment epithelium and choroid. Curr Eye Res 1988; 7: 675-679
59. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-844
60. Kitahara L, Eyre HJ, Lynch R, Rallison ML, Hill HR. Metabolic activity of diabetic monocytes. Diabetes 1980; 29: 251-256
61. van Kuijk FJGM, Buck P. Fatty acid composition of the human macula and peripheral retina. Invest Ophth Vis Sci 1992; 33: 3493-3496
62. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996; 98: 1667-1675
63. Landrum JT, Bone RA, Kilburn MD. The macular pigment. A possible role in protection from age related macular degeneration. Adv Pharmacol 1997; 38: 537-556
64. Landrum JT, Bone RA. Lutein, zeaxanthin and macular pigment. Arch Biochem Biophys 2001; 385: 28-40
65. Liles MR, Newsome DA, Oliver PD. Antioxidant enzymes in the aging human retinal pigment epithelium. Arch Ophthalmol 1991; 109: 1285-1288
66. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial ischemia. Ann Rev Pharmacol Toxicol 1986; 26: 210-224
67. Lynch MA. Lipoic acid confers protection against oxidative injury in non-neural and neuronal tissue. Nutritional Neuroscience 2001; 4: 419-438
68. Lyons TJ. Oxidised low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes. Diabet Med 1991; 8: 411-419
69. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994; 112: 1476-1482
70. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RE Antioxidant nutrient intake and diabetic retinopathy. The San Luis Valley diabetes study. Ophthalmology 1998; 105: 22642270
71. Mc Cord JMC. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163
72. Michelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. Trans Ophthalmol Soc UK 1948; 68: 137-180
73. Miller JW, Adamis AP, Shima DT. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574-584
74. Müller-Breitenkamp U, Ohrloff C, Hockwin O. Aspekte zur physiologie, pathologie und epidemiologie der katarakt. Ophthalmologe 1992; 89: 257-267
75. Muller DP. Vitamin E therapy in retinopathy of prematurity. Eye 1992; 6: 221-225
76. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995; 27: 48-52
77. Noell WK, Albrecht R. Irreversible effects of visible light on the retina: Role of vitamin A. Science 1971; 172: 76-80
78. Noell WK. Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision Res 1980; 20: 1163-1171
79. Ohrloff C, Hockwin O, Olson R, Dickman S. Glutathione peroxidase, glutathione reductase and superoxide dismutase in the aging lens. Curr Eye Res 1984; 3: 109-115
80. Organisciak DT, Wang HM, Kou Al. Ascorbate and glutathione levels in the developing normal and dystrophic rat retina: Effect of intense light exposure. Curr Eye Res 1984; 3: 257-267
81. Owens WC, Owens EU. Retrolental fibroplasia in premature infants II. Studies on the prophylaxis of the disease: The use of alpha- tocopherol acetate. Am J Ophthalmol 1949; 32: 1631-1637
82. Parks DA, Williams TK, Beckmann JS. Conversion of xanthin dehydrogenase to oxidase in ischemic rat intestine: A reevaluation. Am J Physiol 1989; 254: G768-G774
83. Persad S, Menon IA, Basu PK, Carre F. Phototoxicity of chlorpromazine on retinal pigment epithelial cells. Curr Eye Res 1988; 7: 1-9
84. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92: 905-909
85. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: Relationship to early outcome. Free Radical Res 2002; 36: 265-268
86. Pryor WA, Stahl W, Rock CL. Beta-carotene: From biochemistry to clinical trials. Nutr Rev 2000; 58: 39-53
87. Rao PS, Cohen MV, Müller HS. Production of free radicals and lipid peroxides in early myocardial ischemia. J Mol Cell Cardiol 1983; 15: 713-716
88. Rao NA, Thaete LG, Delmage JM, Sevanian A. Superoxide dismutase in ocular structures. Invest Ophth Vis Sci 1985; 26: 1778-1781
89. Rathbun WB. Lenticular glutathione synthesis: Rate-limiting factors in its regulation and decline. Curr Eye Res 1984; 3: 101-108
90. Rösen P, Oestreich R, Tschöpe D. Vitamin and diabetes. Fat Science and Technology 1991; 93: 425-431
91. Rolfsen ML, Davis WR. Cerebral function during cardiac arrest. Crit Care Med 1989; 17: 183-292
92. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T. Blue light-induced reactivity of retinal age pigment. J Biol Chem 1995; 270: 18825-18830
93. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997; 81: 24-33
94. Russell GA, Cooke RW. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child Neonatal Ed 1995; 73: 27-31
95. Ruffolo JJ, Ham WT, Mueller HA, Millen JE. Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest Ophth Vis Sci 1984; 25: 893-898
96. Schalch W. Carotenoids in the retina: A review of their possible role in preventing or limiting damage caused by light and oxygen. In: Emerit 1, Chance B (eds): Free Radicals and Aging. Basel, Switzerland: Birkhäuser Verlag, 1992: 280-298
97. Schmidt-Erfurth U für die PDT Studiengruppe. Photodynamische therapie - Eine schonende alternative zur behandlung der exsudativen makuladegeneration. Klin Monatsbl Augenheilkd 1998; 213: 1115
98. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139: 81-100
99. Shaban H, Richter C. A2E and blue light in the retina: The paradigm of age-related macular degeneration. Biol Chem 2002; 383: 537-545
100. Shvedova AA, Alekseeva OM, Kuliev LY, Muranov KO, Kozlov YuP, Kagan EV. Damage of photoreceptor membrane lipids and proteins induced by photosensitized generation of singlet oxygen. Curr Eye Res 1982; 2: 683-689
101. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000; 118: 327-336
102. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995; 62: 1448S-1461S
103. Spector A. The search of a solution to senile cataracts. Invest Ophth Vis Sci 1984; 25: 130-146
104. Spector A. Oxidation and aspects of ocular pathology. Clao Journal 1990; 16: 8-10
105. Srivastava SK, Ansari NH, Awasthi YC. Lens glutathione depletion of 1-chloro-2,4-dinitrobenzene and oxidative stress. Curr Eye Res 1984; 3: 117-119
106. Stephens RJ, Negi DS, Short SM, van Kuijk FJGM, Dratz EA, Thomas DW. Vitamin E distribution in ocular tissues following longterm dietary depletion and supplementation as determined by microdissection and gas chromatography-mass spectrometry. Exp Eye Res 1988; 47: 237-245
107. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol 1999; 117: 1329-1345
108. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1995; 44: 98-103
109. Thomas PD, Mao GD, Rabinovitch A, Poznanzky MJ. Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). Biochem Pharmacol 1993; 45: 241-251
110. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate. Arch Ophthalmol 1995; 114: 964-970
111. Tolentino MJ. Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103: 1820-1828
112. Toyoda Y, Thomson LR, Langner A, Craft NE, Garnett KM, Nichols CR, Cheng KM, Dorey CK. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail. Invest Ophthalmol Vis Sci 2002; 43: 1210-1221
113. Tso MOM, Woodford BJ, Lamm KW. Distribution of ascorbate in normal primate retina and after photic injury: A biochemical, morphological correlated study. Curr Eye Res 1984; 3: 181-191
114. Uzel N, Sivas A, Uysal M, Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res 1987; 19: 89-90
115. Vaino H. Chemoprevention of cancer: Lessons to be learned from the beta-carotene trials. Toxicol Lett 2000; 15: 513-517
116. Varma SD, Srivastava VK, Richards RD. Photoperoxidation in lens and cataract formation: Preventive role of superoxide dismutase, catalase and vitamin C. Ophthalmic Res 1982; 14: 167-175
117. Varma SD, Richards RD. Ascorbic acid and the eye lens. Ophthalmic Res 1988; 20: 164-173
118. Whilmark U, Wrigstad A, Roberg K, Nilsson SEG, Brunk U. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. Free Rad Biol Med 1997; 22: 1229-1234
119. Wiegand RD, Giusto NM, Rapp LM, Anderson RE. Evidence for rod outer segment lipid peroxidation following constant illumination of the rat retina. Invest Ophth Vis Sci 1983; 24: 1433-1435
120. Wright PS, Loudy DE, Cross-Doersen DE, Montgomery LR, SprinkleCavallo J, Miller JA, Distler CM, Lower EE, Woessner RD. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. Exp Mol Pathol 1997; 64: 41-51
121. Yamashita H, Horie K, Yamamoto T, Nagano T, Hirano T. Light-induced retinal damage in mice. Retina 1992; 12: 59-66
122. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31: 291-306
123. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988; 32: 252-269
124. Zuclich JA. Ultraviolett induced damage in the primate cornea and retina. Curr Eye Res 1984; 3: 27-34